POLYPHARMACY IN PSYCHIATRY - BALANCING CAUTION WITH DARING

被引:1
作者
GELENBERG, AJ
机构
[1] Department of Psychiatry, University of Arizona Health Sciences Center, Tucson, Arizona, 85724
关键词
D O I
10.2165/00023210-199504060-00003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although it is wise to be cautious when administering more than one drug to a patient, polypharmacy is not a controversial practice. Rather, it is a useful and an accepted method of treating complicated cases in all medical specialities. There is a need for more rigorous study of multiple-medication therapies. However, physicians must be able to make decisions based on the data that are available and not be limited in their ability to treat a patient by a lack of scientific validation for every aspect of the treatment.
引用
收藏
页码:410 / 411
页数:2
相关论文
共 6 条
[1]  
AMSTERDAM JD, 1994, J CLIN PSYCHIAT, V55, P394
[2]   FLUOXETINE POTENTIATION BY BUSPIRONE - 3 CASE-HISTORIES [J].
BAKISH, D .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1991, 36 (10) :749-750
[3]  
FREUDENREICH O, 1995, J CLIN PSYCHIAT, V56, P173
[4]   CLOMIPRAMINE - AN OVERVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND A REVIEW OF ITS THERAPEUTIC USE IN OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER [J].
MCTAVISH, D ;
BENFIELD, P .
DRUGS, 1990, 39 (01) :136-153
[5]   THE NEW POLYPHARMACY IN PSYCHIATRY - CLINICAL-PRACTICE AND CLINICAL RESEARCH PART COMPANY [J].
NAFTOLOWITZ, DF ;
DONOVAN, S ;
FRANCES, A .
CNS DRUGS, 1995, 4 (06) :404-409
[6]  
1994, DIAGNOSTIC STATISTIC